The second-generation active Aβ immunotherapy CAD106 reduces amyloid accumulation in APP transgenic mice while minimizing potential side effects.
| Image |  |
|---|---|
| Description | scientific article published in June 2011 |
| Author/s |
author: Martin F. Bachmann Laura H Jacobson |
| Publication date | June 1, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |